Skip to main content
. 2017 Feb 27;8(35):59757–59765. doi: 10.18632/oncotarget.15760

Table 3. Univariate and multivariate analysis of factors associated with recurrence-free survival.

Variables Univariate Multivariate
Hazard ratio P Hazard ratio 95% CI P
NLR 0.008 0.07
Low NLR (≤1.7)
High NLR (>1.7)
1
1.446
1
1.319
0.978-5.087
LMR
Low LMR (≤6.8)
High LMR (>6.8)
1
0.53
0.008 1
0.658
0.405-1.070 0.092
PLR
Low PLR (≤92.88)
High PLR (>92.88)
1
0.765
0.076 1
0.649
0.473-0.89 0.007
ypT stage <0.001 <0.001
ypT0 1 1
ypT1
ypT2
ypT3
ypT4
0.388
1.852
5.216
6.235
0.417
1.694
3.297
3.208
0.097-1.799
0.972-1.449
1.980-5.491
0.74-14.7
ypN stage
ypN0
ypN1
ypN2
1
2.931
5.347
<0.001 1
1.882
2.345
1.385-2.557
1.538-3.575
<0.001
Lymphovascular invasion 3.637 <0.001 1.762 1.229-2.526 0.002
Perineural invasion 3.195 <0.001 1.509 1.093-2.083 0.012
Age, yrs
≤70
>70
1
1.09
0.648
Gender
Male
Female
1
0.893
0.431

NLR, neutrophil to lymphocyte ratio; LMR, lymphocyte to monocyte ratio; PLR, platelet to lymphocyte ratio